Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,063 | -171,855 | -118,929 | -75,382 | -41,097 |
| Depreciation Amortization | 3,628 | 14,508 | 10,810 | 6,952 | 3,510 |
| Accounts receivable | 2,158 | -867 | 1,027 | -6,423 | -5,865 |
| Accounts payable and accrued liabilities | 1,355 | -122 | -401 | 80 | -1,290 |
| Other Working Capital | 7,790 | 1,606 | 5,662 | -863 | -5,020 |
| Other Operating Activity | 2,021 | 26,974 | 19,451 | 20,427 | 15,144 |
| Operating Cash Flow | $-38,111 | $-129,756 | $-82,380 | $-55,209 | $-34,618 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -316 | -10,583 | -5,744 | -3,172 | -1,516 |
| Purchase Of Investment | -56,336 | -164,662 | -126,609 | -120,410 | -102,023 |
| Sale Of Investment | 100,338 | 313,265 | 208,146 | 179,766 | 151,964 |
| Other Investing Activity | 0 | -25,000 | -25,000 | 0 | 0 |
| Investing Cash Flow | $43,686 | $113,020 | $50,793 | $56,184 | $48,425 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -692 | 77,940 | 78,006 | N/A | N/A |
| Debt Repayment | N/A | -174,844 | -174,180 | -1,151 | -566 |
| Common Stock Issued | 1,218 | 4,117 | 3,177 | 1,337 | 479 |
| Other Financing Activity | -3,000 | 119,588 | 119,588 | 119,589 | 119,589 |
| Financing Cash Flow | $-2,474 | $26,801 | $26,591 | $119,775 | $119,502 |
| Exchange Rate Effect | -7 | 60 | 22 | 92 | -136 |
| Beginning Cash Position | 25,437 | 15,312 | 15,312 | 15,312 | 15,312 |
| End Cash Position | 28,531 | 25,437 | 10,338 | 136,154 | 148,485 |
| Net Cash Flow | $3,094 | $10,125 | $-4,974 | $120,842 | $133,173 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,111 | -129,756 | -82,380 | -55,209 | -34,618 |
| Capital Expenditure | -316 | -10,583 | -5,744 | -3,172 | -1,516 |
| Free Cash Flow | -38,427 | -140,339 | -88,124 | -58,381 | -36,134 |